CN105878573A - Composition for relieving visual fatigue - Google Patents
Composition for relieving visual fatigue Download PDFInfo
- Publication number
- CN105878573A CN105878573A CN201610341057.7A CN201610341057A CN105878573A CN 105878573 A CN105878573 A CN 105878573A CN 201610341057 A CN201610341057 A CN 201610341057A CN 105878573 A CN105878573 A CN 105878573A
- Authority
- CN
- China
- Prior art keywords
- extract
- composition
- cowberry
- matrimony vine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 239000000284 extract Substances 0.000 claims abstract description 62
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 46
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 41
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 40
- 235000016357 Mirtillo rosso Nutrition 0.000 claims abstract description 28
- 244000077923 Vaccinium vitis idaea Species 0.000 claims abstract description 28
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims abstract description 28
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 19
- 235000012680 lutein Nutrition 0.000 claims abstract description 15
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 15
- 239000001656 lutein Substances 0.000 claims abstract description 15
- 229960005375 lutein Drugs 0.000 claims abstract description 15
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 15
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 15
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 11
- 240000000785 Tagetes erecta Species 0.000 claims abstract 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 238000002360 preparation method Methods 0.000 claims description 26
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 23
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 23
- 241000628997 Flos Species 0.000 claims description 20
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000005881 Calendula officinalis Nutrition 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- -1 C1~C4Alcohol Substances 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 6
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 6
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 6
- 235000004634 cranberry Nutrition 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 235000013402 health food Nutrition 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 3
- 239000004106 carminic acid Substances 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims description 2
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 claims 1
- 235000002710 Ilex cornuta Nutrition 0.000 claims 1
- 241001310146 Ilex cornuta Species 0.000 claims 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 210000001508 eye Anatomy 0.000 abstract description 33
- 208000024891 symptom Diseases 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 10
- 206010034960 Photophobia Diseases 0.000 abstract description 5
- 206010047513 Vision blurred Diseases 0.000 abstract description 5
- 230000004310 photopic vision Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 235000018927 edible plant Nutrition 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 206010015958 Eye pain Diseases 0.000 abstract 1
- 235000012311 Tagetes erecta Nutrition 0.000 abstract 1
- 235000003595 Tagetes minuta Nutrition 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 208000021792 sore eyes Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000004438 eyesight Effects 0.000 description 10
- 241000736851 Tagetes Species 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229930014669 anthocyanidin Natural products 0.000 description 8
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 8
- 235000008758 anthocyanidins Nutrition 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 230000004379 myopia Effects 0.000 description 5
- 208000001491 myopia Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 208000030533 eye disease Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241001134654 Lactobacillus leichmannii Species 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000001748 carotenols Chemical class 0.000 description 2
- 235000005471 carotenols Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 210000000695 crystalline len Anatomy 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 230000004344 low myopia Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 201000002287 Keratoconus Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- UDEWPOVQBGFNGE-UHFFFAOYSA-N benzoic acid n-propyl ester Natural products CCCOC(=O)C1=CC=CC=C1 UDEWPOVQBGFNGE-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000001542 lens epithelial cell Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
The invention discloses a composition for relieving visual fatigue. The composition can be used as a medicine or as a functional food composition used for preventing or improving visual fatigue and can contain pharmaceutically acceptable carriers and effective quantities of raw material extracts, wherein the raw material extracts include cowberry or a cowberry extract, barbary wolfberry fruit or a barbary wolfberry fruit extract and lutein or an extract of flower of Aztec marigold. The composition has the function of preventing, improving or treating visual fatigue and the function of handling at least one of the symptoms including sore eyes, eye distension, photophobia, blurred vision and dry eyes and can achieve the effect of improving the duration of photopic vision. Prepared from pure natural medicinal and edible plant extracts, the composition is safe to use, does not have any toxic or side effect and has stable and controllable quality.
Description
Technical field
The present invention relates to a kind of composition for relieving asthenopia.
Background technology
Communication society, it is daily that the video display terminal (vdt) such as computer, television set, game machine has penetrated into us
The every nook and cranny of life, user gets more and more;Adding study and work pressure big, social competition is the most sharp
Strong so that a series of syndrome such as visual fatigue also gets more and more, they are deeply dry and astringent by eyes, foreign body sensation, eye
Fatigue, eyelid sense of heaviness, blurred vision, photophobia are shed tears, eye distending pain, eye hyperemia and other eye disease
Puzzlement.Severe patient it is also possible that headache, dizzy, feel sick, One's spirits are drooping, absent minded, note
Recall power to decline, lose the appetite and the whole body disease such as neck shoulder aching pain in waist and back and articulations digitorum manus numbness, some patients
There is also diplopia, stereoscopic vision dysfunction, intraocular pressure rising, corneal injury etc..
A statistics according to the World Health Organization, the whole world has 100,000,000 8 thousand ten thousand crowds to suffer from various types of eye
Portion's disease.It is reported, in the experimenter carrying out conventional ophthalmic inspection with the presence of 10%~15% people with calculate
The machine relevant headache of work and visual fatigue, have video display terminal (VDT) operator of about 33.5% to claim visual fatigue,
And have the trend of growth.The existing people more than 800,000,000 of China wears glasses but also is increasing year by year, and sight protection is
Through being instant problem, especially adolescent myopia.Therefore, there is expert call: increasingly sharpen is near
The healthy commonplace problem of infringement Chinese Youth's has been become depending on rate, such as the control that do not takes effective measures, we
" nationality worn glasses " will be become.One joint investigation of the Ministry of Education in 2006 and the Ministry of Public Health shows, China
The rate of myopia of middle school student reaches 34.6%, and high school student's rate of myopia reaches 70%, and university student's rate of myopia is up to 83%, closely
Ranking the first in the world depending on number of the infected, the incidence of disease is only second to Japan and occupies second place of the world.Therefore, have extensively
Suitable population.In recent years, from conventional medicament and natural resources, new raw material is found by world wide
The extensive attention of medical personal.
Summary of the invention
It is an object of the invention to provide one to be effective to prevention, improve or treat asthenopic composition.
The composition for relieving asthenopia that the present invention provides, including cowberry or Bilberry fruit P.E;Matrimony vine or matrimony vine
Extract;And, lutein or Flos Tagetis Erectae extract.
Cowberry, is commonly called as blueberry, is a kind of perennial shrub, originates in Northern Europe, North America and Canada, is working as
Use it for treating diabetes and the longest history of eye disease.Ripe cranberry is rich in flavonoids
Pigment and the anthocyanidin as antibiotic.China cowberry rich in anthocyanidin, the coloring matter in cowberry anthocyanidin,
Predominantly anthocyanidin-2-glucoside, anthocyanidin-3-xyloside, anthocyanidin-3-galactoside, anthocyanidin-2-
Rhamnoside, delphinium-3-rhamnoside, delphinium-5-glucoside, the former delphinidin of 3-O-acyl, high mallow look
Element-3,5-bioside etc..Bilberry fruit P.E, by improving oxygen and blood-transmitted to the ability of eye, improves eye merit
Can, improve and alleviate visual fatigue.Healthy People or the alone Bilberry fruit P.E of vision disorder patient or take simultaneously β-
Carrotene and vitamin E, can obviously improve night vision, very fast to dark reaction, and eye is exposed to light
Afterwards, visual acuity can comparatively fast be recovered.Anthocyanidin is the elite extract of cowberry, can be effectively improved visual fatigue disease
Shape, improves myopia and the distant vision of low myopia in early days.China scientist utilizes the flavones extracted from cowberry
Some health foods that class anthocyanidin active principle is made, it is mainly composed of anthocyanidin, can increase ciliary muscle
CBF, eliminates visual fatigue and related symptoms, improves eye microcirculation, promotes the regeneration of visual purple red pigment, carries
The function of high optic cell, strengthens eye to the adaptability to changes of light intensity and dark adaptation ability.Improve because regarding
The pseudo-myopia that fatigue causes, stops the development of low myopia, the antioxidation of anthocyanidin, can prevent eye
Portion's lipid peroxidation, effectively removes the infringement of radical pair eyeball tissue.
Matrimony vine is the fruit of plant of Solanaceae lycium barbarum.Tcm health preserving theory thinks " liver opening at eye ".The most just
It is to say, eyeshield liver to be protected simultaneously.Matrimony vine energy nourishing liver filling liver kidney, benefiting shrewd head.Cure mainly consumptive disease essence to lose, dizzy
Dizzy tinnitus, blurred vision is failed to understand.As " book on Chinese herbal medicine converges and says " is recorded: " matrimony vine can make gas to fill, and blood can be mended, and sun can
Raw, the moon can be grown, and rheumatism is dispelled, and here has perfect magical effect." wolfberry fruit extract brownish-yellow powder, easy moisture absorption, molten
Yu Shui, it is mainly composed of LBP-X.This polysaccharide system proteoglycan, molecular weight is 22~25kD, by Ah
Draw 6 kinds of monosaccharide components compositions such as uncle sugar, glucose, galactolipin, mannose, wood sugar, rhamnose.Matrimony vine
Extract can effectively protect retinal ganglial cells;LBP-X can substantially Inhibition test crystalline lens oxidation
Lens epithelial cell apoptosis caused by damage, protects eyesight, alleviates visual fatigue.
Lutein belongs to the one of carotenoid, jointly exists with luteole in nature.Marigold
It it is plant the abundantest containing natural carotenol and luteole at present.Tagetes in composite family perennial plant,
Containing natural carotenol, luteole, anthocyanidin, vitamin, mineral matter etc., these nutrients all cannot
Human body synthesizes voluntarily, it is necessary to absorb from diet.
Lutein is water insoluble, is soluble in grease and fatty solvent.Pure lutein is that rib trellis yellow is brilliant
Body, has metallic luster, unstable to light and hydrogen, need to be stored in the shady and cool place that is dried, lucifuge sealing, be to constitute
The key component of the phytochromes such as corn, veterinary antibiotics, flowers, has protection to photooxidation, photo damage
Effect.Also it is the primary pigments constituting human eye retina's macular region.Lutein can protect the eyes from light
Infringement, delays eyes aging, prevents pathology.Lutein has expansion blood vessel and anti-oxidation function, can improve
Eye microcirculation, improves eye nutrition supply, prevents the oxidative damage of radical pair eye, allows eyes obtain
Sufficient blood supply, strengthens retina collagen structure, thus protects eyesight, alleviates visual fatigue.
The composition of the present invention is on the basis of Traditional Chinese medical theory and modern pharmacological research, and meticulous prescription forms,
Lutein can protect macula retinae and improve eye microcirculation, is retina and class that crystalline lens uniquely exists
One of carrotene;Theoretical " liver opening at eye " according to tcm health preserving, matrimony vine can be nourishing liver and kidney, benefiting shrewd head,
Also liver can be protected while eyeshield;Bilberry fruit P.E improves oxygen and blood-transmitted to the abilities such as eye, raising eye
Nutrition, can comparatively fast recover visual acuity simultaneously, and three acts synergistically from different perspectives, has reached to protect eyesight,
Improving eye function, alleviate visual fatigue, its effect is better than folk prescription.
Bilberry fruit P.E, wolfberry fruit extract and Flos Tagetis Erectae extract all can directly buy commercial goods.Also may be used
It is prepared by arbitrary extracting method known in the art.
Be exemplified below one preferably extracting method, can with fast and easy and high-purity extract Bilberry fruit P.E,
Wolfberry fruit extract or Flos Tagetis Erectae extract:
1) raw material is at 10 DEG C to 80 DEG C, preferably carries out under room temperature (about 25 DEG C), preferably 1~3 day, carries
Access method such as has hot water extracting, cold soaking to extract, returned cold is extracted or ultrasonically treated, and preferably cold soaking extracts 1~5
Secondary;The solvent extractable matter that filtration under diminished pressure obtains, at 20 DEG C to 100 DEG C, preferably under room temperature (about 25 DEG C),
Utilize Rotary Evaporators reduced pressure concentration filtrate, thus obtain final extract.
Further, described step 1) in the carrying of Bilberry fruit P.E, wolfberry fruit extract or Flos Tagetis Erectae extract
Taking solvent is water, C1~C4In alcohols, acetone, chloroform, dichloromethane, ether, ethyl acetate and hexane
One or more.Wherein optimal with ethanol.
Further, described step 1) in the preparation method of Bilberry fruit P.E be: take cowberry dry fruit, wash
Squeezing after clean, pressed liquor uses stainless steel mesh to filter, and filtrate water dilutes and is uniformly dispersed, obtaining cowberry
Fruit pressed liquor;By cranberry pressed liquor Dynamic Adsorption in the AB-8 macroreticular resin pre-processed, first
With water elution, elution flow rate is 60L/h, discards water elution liquid;Again with the ethanol of concentration expressed in percentage by volume 70%
Wash-out, elution flow rate is 30L/h, collects ethanol eluate, obtains cowberry active component eluent;Gained
Cowberry active component eluent be evaporated to relative density 1.05~1.20, then drying under reduced pressure, dried object powder
Broken, obtain Bilberry fruit P.E.Wherein, the pretreatment of AB-8 macroreticular resin is according to the product of AB-8 macroreticular resin
Product specification is carried out, and uses ethanol-water system activation process.
Further, described step 1) in the preparation method of wolfberry fruit extract be: matrimony vine is in the water of 85~95 DEG C
Extracting twice, each 2 hours, extract uses stainless steel mesh to filter, and reduced pressure concentration after cooling concentrates
Liquid adds ethanol, and adjusting ethanol concentration expressed in percentage by volume is 80%, obtains the 80% ethanol precipitated liquid of matrimony vine, heavy
After the drying under reduced pressure of shallow lake, pulverize and make powder.
Further, described step 1) in the preparation method of Flos Tagetis Erectae extract be: marigold clean after through de-
Marigold particles is made in water, drying, and in fermentation cylinder for fermentation, the marigold particles after fermenting is placed in
The n-hexane of 55~65 DEG C leaches 1.5h, filters, by medicinal extract at 66~70 DEG C after pressurization recovery n-hexane
Saponification 5~10h in KOH solution, filter, drying under reduced pressure, obtain Flos Tagetis Erectae extract.Marigold particles
Fermentation strain is preferably used one or more in Lactobacillus plantarum, lactobacillus leichmannii or streptococcus thermophilus.
2) Bilberry fruit P.E, wolfberry fruit extract and Flos Tagetis Erectae extract all arbitrary can be had by known in the art
Effect composition isolation and purification method carry out adsorption, including solvent segregation (liquid-liquid extraction), the precipitation method,
Dialysis, chromatography etc..Wherein refining for Bilberry fruit P.E, first-selection is column chromatography, all fillers
Can be the one or more combination in silica gel, polyamide or macroreticular resin, the most preferably macroreticular resin;
Big pore resin can be the non-pole such as HPD100, HPD300, HPD700, D101, AB-8, X-5
Property or low pole macroporous type polymeric adsorbent, or the compound resin of Several combinations, the most preferably D101 macropore
Polymeric adsorbent, this resin destroys minimum for cowberry active ingredient, it is possible to retain more active ingredient.
3) composition for relieving asthenopia described in any of the above, each Ingredient Amount is: cowberry or cowberry are extracted
Thing 0.1~250 weight portion;Matrimony vine or wolfberry fruit extract 0.1~150 weight portion;Lutein or Flos Tagetis Erectae extract
0.1~200 weight portions.
Further, each Ingredient Amount is preferably: cowberry or Bilberry fruit P.E 120~220 weight portion;Matrimony vine or
Wolfberry fruit extract 80~90 weight portion;Lutein or Flos Tagetis Erectae extract 110~200 weight portion.
Present invention also offers the composition for relieving asthenopia described in any of the above and alleviate asthenopic medicine
Thing, health food for alleviating eye fatigue or alleviate the application in asthenopic beverage.
In terms of preparation is used for alleviating asthenopic medicine, the composition of the present invention can add and pharmaceutically can connect
The carrier being subject to or additive, make any dosage form, preferred tablet, capsule, granule, powder, outstanding
Supernatant liquid, emulsion, syrup, or oral formulations.
When making oral formulations, can be selected for diluent, lubricating oil, binding agent, disintegrant, sweetener, steady
Determine one or more in agent and preservative as carrier, can be selected in flavoring agent, vitamin and antioxidant
One or more as additive.Carrier and additive can be any pharmaceutically acceptable examples.
In particular, it is preferred that diluent include: lactose, glucose, dextrin, sucrose, cornstarch, soya-bean oil,
Microcrystalline cellulose, sorbierite, xylitol and mannitol, preferred lubricant includes magnesium stearate and talcum,
Preferred binder includes polyvinylpyrrolidone or carboxy-propyl cellulose.Additionally, it is preferred that disintegrant include:
Calcium carboxymethylcellulose, carboxyrnethyl starch sodium, polyacrylic acid potassium or Crospovidone, the example of preferred sweetener
Including: white sugar, fructose, sorbierite or Aspartame, preferred stabilizer includes: sodium carboxymethylcellulose,
Beta-schardinger dextrin, hundred beeswaxs and xanthans, preferred preservative includes: methyl p-hydroxybenzoate, to hydroxyl
Propyl benzoate and potassium sorbate.In addition to these compositions, also can comprise and add for improving the known of taste
Add agent, such as: natural flavouring, such as plum, lemon, pineapple or medicinal herbs taste.Fruit juice, natural
Dyestuff, such as chlorophyllin or flavonoids, sweetener component, such as fructose, honey, sugar alcohol or sugar or
Acidulant such as citric acid or sodium citrate.
During preparation Asthenopia-relievinghealthcare healthcare food, can be prepared as following form: powder, particle,
Tablet, pill, capsule, suspension, emulsion, syrup, chewing gum, tea, jelly etc..Can in sitology
The carrier or the additive that accept can be any carrier known in the art or additive.
When preparation is used for alleviating asthenopic beverage, except above-mentioned herbal ingredients, this beverage also can comprise it
His component, other components described can be the various flavor enhancements or natural carbohydrate used in conventional beverage.
The example of above-mentioned natural carbohydrate is conventional sugar, such as monose (such as glucose or fructose etc.), disaccharides (as
Maltose, sucrose etc.) and polysaccharide (such as glucan, cyclodextrin etc.), and sugar alcohol, such as xylitol, sorb
Alcohol and antierythrite.Also other flavor enhancements, natural flavouring can be added (such as thaumatin, STEVIA REBAUDIANA
Extract etc.) and synthesis flavor enhancement (such as saccharin, Aspartame etc.).
Further, in above-mentioned application, when preparing Asthenopia-relievinghealthcare healthcare food, described combination
The addition of thing accounts for the 0.01~15% of health food gross weight, preferably up to 0.2~10% weight;Preparation is used for delaying
When solving asthenopic beverage, every 100ml beverage contains described composition 0.1~30g, preferably 0.2g to 5g.
The method have the advantages that
The composition of the present invention includes medicinal and edible plant extract, without any side effects, in prevention, changes
Kind or treatment visual fatigue presents unexpected effect, including reply ophthalmodynia, eye is swollen, photophobia, regarding thing
At least one symptom during fuzzy, eye is dry and astringent, can improve duration of photopic vision.
In order to weigh its to asthenopic mitigation, select long-term eye, the fatigable adult of eyesight,
Once a day, each 2 payment capsules of being prepared from of above-mentioned composition, by visual fatigue situation interrogation,
The metrics evaluation such as visuognosis persistence test and distant vision mensuration.Compared with placebo (control group), result
Show ophthalmodynia, eye is swollen, photophobia, blurred vision, eye are dry and astringent etc., and clinical symptoms have improvement.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, so that those skilled in the art is permissible
It is better understood from the present invention and can be practiced, but illustrated embodiment is not as a limitation of the invention.
Embodiment 1 has the composition alleviating visual fatigue effect, and its preparation method comprises the following steps:
Step 1, the preparation of Bilberry fruit P.E: take cowberry dry fruit 20kg, squeeze after cleaning, pressed liquor
Employing stainless steel mesh filters, and filtrate water dilutes and is uniformly dispersed, and obtains 30L cranberry pressed liquor;
By cranberry pressed liquor Dynamic Adsorption in the AB-8 macroreticular resin pre-processed with ethanol water, first with
150L water elution, elution flow rate is 60L/h (1000ml/h), discards water elution liquid;Again with 120L 70%
Ethanol (V/V) elutes, and elution flow rate is 30L/h (500ml/min), collects 70% ethanol eluate,
To cowberry active component eluent;The cowberry active component eluent of gained is evaporated to relative density
1.05~1.20 (60 DEG C of mensuration), then at 60 DEG C of drying under reduced pressure, dried object is pulverized, is obtained the cowberry of the present invention
Functional component group extract.
Step 2, the preparation of wolfberry fruit extract: choose matrimony vine, extraction twice in the water of 85~95 DEG C, every time
2 hours, extract used stainless steel mesh to filter, reduced pressure concentration after cooling, and concentrate uses and adds ethanol,
Adjusting concentration of alcohol is 80% (concentration of volume percent), obtains the 80% ethanol precipitated liquid of matrimony vine, precipitation
After drying under reduced pressure, pulverize and make powder, obtain the matrimony vine functional component group extract of the present invention.
Step 3, the preparation of Flos Tagetis Erectae extract: choose marigold clean after, through dehydration, dry make ten thousand
Longevity chrysanthemum granules, with Lactobacillus plantarum, lactobacillus leichmannii and the mixed culture fermentation agent of streptococcus thermophilus in fermentation tank
Carry out ferment (leavening inoculum concentration is the 0.1% of marigold particles quality), by the marigold particles after fermentation
Being placed in the n-hexane of 55~65 DEG C leaching 1.5h, filter, lutein extract is existed after reclaiming n-hexane by pressurization
Saponification 5~10h in the KOH solution of 66~70 DEG C, filter, drying under reduced pressure, obtain Flos Tagetis Erectae extract (main
Wanting composition is lutein).
Embodiment 2 one kinds has the preparation of the medicinal granule of efficacy of relieving visual fatigue
The Bilberry fruit P.E powder 120g of preparation, Flos Tagetis Erectae extract 200g and matrimony vine in above-described embodiment 1
Extract 90g mixes, and adds dextrin 37g and magnesium stearate 3g, mixes, and making granularity is 16 mesh
Drug particles, obtain the medicinal granule of the efficacy of relieving visual fatigue of the present invention.
Embodiment 3 one kinds has the preparation of the medicine capsule of efficacy of relieving visual fatigue
The Bilberry fruit P.E powder 220g of preparation, lutein 110g and wolfberry fruit extract in above-described embodiment 1
80g mixes, and adds dextrin 37g and magnesium stearate 3g, mixes, make the medicine that granularity is 16 mesh
Grain, loads capsule, obtains the medicine capsule of the efficacy of relieving visual fatigue of the present invention.
Embodiment 4
Use embodiment 2 and the asthenopic granule of alleviation of embodiment 3 preparation or capsule treatment visual fatigue
Disease.Selecting long-term eye, the fatigable adult of eyesight is as tested crowd.All meet above-mentioned condition and from
It is willing to participate in and ensure that cooperation person all includes test in;To not meeting the experimenter including age criterion in, to health care food
Product allergy sufferers, suffers from infectious eye disease person, the inside and outside eye disease patient such as nebula, keratoconus, suffers from
There is fundus oculi disease or be associated with the diseases such as cardiovascular, the cerebrovascular, liver, kidney, hemopoietic system, take in a short time
Article relevant with tested function, have influence on the judgement person to result, other relevant treatment eyesights of long-term taking
Medicine or use other treatment method to fail terminator etc. the most not include data statistics in.Use between self and group two
Plant control design, according to random, the requirement of double blinding, inclusive criteria will be met and ensure the voluntary of compatibility test
Experimenter, according to symptom, eye test situation, consider the age simultaneously, the factor of sex is divided into test-meal group and
Control group.Test-meal group takes granule sample or capsule according to RD, and control group takes placebo, even
Continuous 45 days.Original eating habit, normal diet is not changed during test.
Inventor carries out statistical analysis to following functions index:
Symptom Observation: in detail inquiry visual fatigue situation, observes ophthalmodynia, eye is swollen, photophobia, blurred vision, eye
The symptom such as dry and astringent, by mild symptoms multiple integral (severe 3 points, middle disease 2 points, mild 1 point) before and after test-meal
Statistics integrated value, and (arbitrary symptom improves 1 point and above for improving) situation is improved with regard to its symptom, observe
Symptom improvement rate.
Visuognosis persistence test.
Distant vision measures.
Symptom integral system before and after the medicine composition for relieving eyestrain test-meal of table 1. embodiment 2 and embodiment 3 preparation
Meter
Group | Before test-meal | After test-meal |
Control group | 8.55±1.10 | 8.26±1.15 |
Embodiment 2 | 8.53±1.26 | 7.13±1.21*# |
Embodiment 3 | 8.49±1.08 | 7.01±1.01*# |
* compare with control group, P < 0.05,#Compare with self, P < 0.05.
Before and after the alleviation visual fatigue pharmaceutical composition test-meal of table 2. embodiment 2 preparation, symptom improves situation
Before and after the alleviation visual fatigue pharmaceutical composition test-meal of table 3. embodiment 3 preparation, symptom improves situation
Before and after the alleviation visual fatigue pharmaceutical composition test-meal of table 4. embodiment 2 and embodiment 3 preparation, function is observed and is compared
* compare with control group, P < 0.05.
The alleviation visual fatigue pharmaceutical composition impact on duration of photopic vision of table 4 embodiment 2 and embodiment 3 preparation
Group | Before test-meal | After test-meal | Increase rate |
Control group | 0.54±0.06 | 0.54±0.06 | 0.02±0.01 |
Embodiment 2 groups | 0.55±0.06 | 0.66±0.07*# | 0.11±0.01 |
Embodiment 3 groups | 0.52±0.06 | 0.64±0.12*# | 0.12±0.06 |
* compare with control group, P < 0.05;#Compare with self, P < 0.05.
Before and after table 5. same dose order side 1 (Bilberry fruit P.E) test-meal, symptom improves situation
Before and after table 6. same dose order side 2 (wolfberry fruit extract) test-meal, symptom improves situation
Before and after table 7. same dose order side 3 (Flos Tagetis Erectae extract) test-meal, symptom improves situation
Table 8. same dose order side improves the contrast and experiment of situation with compound duration of photopic vision
Control group | Compound 1 | Compound 2 | Folk prescription 1 | Folk prescription 2 | Folk prescription 3 |
Placebo | Embodiment 2 | Embodiment 3 | Bilberry fruit P.E | Wolfberry fruit extract | Flos Tagetis Erectae extract |
0.54±0.06 | 0.66±0.07* | 0.64±0.12* | 0.59±0.03* | 0.58±0.06* | 0.61±0.05* |
* compare with control group, P < 0.05.
Wherein, Bilberry fruit P.E powder, Flos Tagetis Erectae extract and wolfberry fruit extract in embodiment 2 and embodiment 3
Total amount accounts for the 91.11% of pharmaceutical preparation gross mass, and folk prescription 1~3 is respectively respective extract 100%.Pass through table
8 it can be seen that in the case of each Ingredient Amount is less, the drug effect of composition is in duration of photopic vision improvement side
The effect in face is substantially better than the folk prescription component that consumption is more.
Embodiment described above is only the preferred embodiment lifted by absolutely proving the present invention, the present invention's
Protection domain is not limited to this.Equivalent that those skilled in the art are made on the basis of the present invention substitute or
Conversion, all in protection scope of the present invention.
Claims (9)
1. a composition for relieving asthenopia, it is characterised in that described composition contains the cowberry of effective dose
Or Bilberry fruit P.E;Matrimony vine or wolfberry fruit extract;And, lutein or Flos Tagetis Erectae extract.
Composition for relieving asthenopia the most according to claim 1, it is characterised in that described cowberry
The Extraction solvent of extract, wolfberry fruit extract or Flos Tagetis Erectae extract is water, C1~C4Alcohol, acetone, chloroform,
One or more in dichloromethane, ether, ethyl acetate and hexane.
Composition for relieving asthenopia the most according to claim 2, it is characterised in that described cowberry carries
The preparation method taking thing is: take cowberry dry fruit, squeezes after cleaning, and pressed liquor uses stainless steel mesh mistake
Filter, filtrate water dilutes and is uniformly dispersed, and obtains cranberry pressed liquor;By dynamic for cranberry pressed liquor
Being adsorbed in the AB-8 macroreticular resin pre-processed, first with water elution, elution flow rate is 60L/h, discards washing
De-liquid;Again with concentration expressed in percentage by volume 70% ethanol elution, elution flow rate is 30L/h, collects ethanol eluate,
Obtain cowberry active component eluent;The cowberry active component eluent of gained is evaporated to relative density
1.05~1.20, then drying under reduced pressure, dried object is pulverized, is obtained Bilberry fruit P.E.
Composition for relieving asthenopia the most according to claim 2, it is characterised in that described matrimony vine carries
The preparation method taking thing is: matrimony vine is extracted twice in the water of 85~95 DEG C, and each 2 hours, extract was adopted
Filtering with stainless steel mesh, reduced pressure concentration after cooling, concentrate adds ethanol, adjusts ethanol volume basis dense
Degree is 80%, obtains the ethanol precipitated liquid of matrimony vine, after precipitation drying under reduced pressure, pulverizes and make powder, obtain Chinese holly
Qi extract.
Composition for relieving asthenopia the most according to claim 2, it is characterised in that described marigold
The preparation method of extract is: marigold makes marigold particles, at fermentation tank through dehydration, drying after cleaning
Middle fermentation, is placed in the n-hexane of 55~65 DEG C leaching 1.5h by the marigold particles after fermentation, filters, add
Push back medicinal extract saponification 5~10h in the KOH solution of 66~70 DEG C after receipts n-hexane, filter, drying under reduced pressure,
Obtain Flos Tagetis Erectae extract.
6. according to the arbitrary described composition for relieving asthenopia of Claims 1 to 5, it is characterised in that respectively become
Demultiplexing amount is: cowberry or Bilberry fruit P.E 0.1~250 weight portion;Matrimony vine or wolfberry fruit extract 0.1~150 weight
Part;Lutein or Flos Tagetis Erectae extract 0.1~200 weight portion.
Composition for relieving asthenopia the most according to claim 6, it is characterised in that each Ingredient Amount
For: cowberry or Bilberry fruit P.E 120~220 weight portion;Matrimony vine or wolfberry fruit extract 80~90 weight portion;Leaf
Flavine or Flos Tagetis Erectae extract 110~200 weight portion.
8. the arbitrary described composition for relieving asthenopia of claim 1~7 is used for alleviating asthenopic in preparation
Medicine, health food for alleviating eye fatigue or alleviate the application in asthenopic beverage.
Application the most according to claim 8, when preparing Asthenopia-relievinghealthcare healthcare food, institute
The addition stating composition accounts for the 0.01~15% of health food gross weight, and preparation is used for alleviating asthenopic beverage
Time, every 100ml beverage contains described composition 0.1~30g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610341057.7A CN105878573A (en) | 2016-05-20 | 2016-05-20 | Composition for relieving visual fatigue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610341057.7A CN105878573A (en) | 2016-05-20 | 2016-05-20 | Composition for relieving visual fatigue |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105878573A true CN105878573A (en) | 2016-08-24 |
Family
ID=56716641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610341057.7A Pending CN105878573A (en) | 2016-05-20 | 2016-05-20 | Composition for relieving visual fatigue |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105878573A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106701381A (en) * | 2016-12-20 | 2017-05-24 | 广州聚澜健康产业研究院有限公司 | Female healthcare wine capable of relieving eyestrain |
CN107997048A (en) * | 2017-11-29 | 2018-05-08 | 中国科学院兰州化学物理研究所 | A kind of composition for having effects that to improve eyesight |
CN108079127A (en) * | 2017-12-31 | 2018-05-29 | 珠海大爱科技有限公司 | A kind of eye strain of releiving, dry and astringent, acid is swollen, promotes the moxa of uncorrected visual acuity |
CN108095112A (en) * | 2017-12-18 | 2018-06-01 | 苏州诺衡生命科技有限公司 | One kind contributes to health food for relieving visual fatigues of health food and preparation method |
CN108260778A (en) * | 2016-12-30 | 2018-07-10 | 西藏天麦力健康品有限公司 | It is a kind of that there is protection eyesight, antifatigue health food and its processing method |
CN108542970A (en) * | 2018-03-08 | 2018-09-18 | 安徽九华华源药业有限公司 | Alleviate the health products and preparation method thereof of asthenopia |
CN109010375A (en) * | 2018-09-11 | 2018-12-18 | 厦门阿欧客健康科技有限公司 | A kind of collyrium |
CN109770364A (en) * | 2019-03-07 | 2019-05-21 | 通化禾韵现代农业股份有限公司 | With composition, the preparation method and application for alleviating visual fatigue function |
CN110384235A (en) * | 2018-04-20 | 2019-10-29 | 浙江新维士生物科技有限公司 | Improve food compositions, the oral preparation and preparation method thereof of visual fatigue |
CN111248448A (en) * | 2020-02-10 | 2020-06-09 | 云南中科本草科技有限公司 | Composition for relieving eye fatigue, preparation method thereof and medicine or health food for relieving eye fatigue |
CN112336761A (en) * | 2020-12-04 | 2021-02-09 | 广州陈锦济生物科技有限公司 | Anti-radiation eye moistening liquid and preparation method thereof |
CN112586646A (en) * | 2020-02-28 | 2021-04-02 | 河北康平健康产业有限责任公司 | Solid beverage with eyesight protecting and asthenopia relieving functions and preparation method thereof |
CN113273690A (en) * | 2021-06-08 | 2021-08-20 | 烟台阿波罗生物药业科技有限公司 | New resource food for improving asthenopia |
CN113332362A (en) * | 2020-03-02 | 2021-09-03 | 张腾龙 | Application of pharmaceutical composition in preparing medicine for treating pseudomyopia |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101856118A (en) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | Health-care food for relieving asthenopia and preparation method thereof |
CN103584101A (en) * | 2013-11-20 | 2014-02-19 | 山西振东五和健康食品股份有限公司 | Asthenopia-relieving healthcare food and preparation method thereof |
CN104957616A (en) * | 2015-06-30 | 2015-10-07 | 湖南炎帝生物工程有限公司 | Health-care food having function of relieving visual fatigue |
CN104958364A (en) * | 2015-06-14 | 2015-10-07 | 威海紫光金奥力生物技术有限公司 | Production method for cowberry lutein preparation capable of relieving asthenopia |
-
2016
- 2016-05-20 CN CN201610341057.7A patent/CN105878573A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101856118A (en) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | Health-care food for relieving asthenopia and preparation method thereof |
CN103584101A (en) * | 2013-11-20 | 2014-02-19 | 山西振东五和健康食品股份有限公司 | Asthenopia-relieving healthcare food and preparation method thereof |
CN104958364A (en) * | 2015-06-14 | 2015-10-07 | 威海紫光金奥力生物技术有限公司 | Production method for cowberry lutein preparation capable of relieving asthenopia |
CN104957616A (en) * | 2015-06-30 | 2015-10-07 | 湖南炎帝生物工程有限公司 | Health-care food having function of relieving visual fatigue |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106701381A (en) * | 2016-12-20 | 2017-05-24 | 广州聚澜健康产业研究院有限公司 | Female healthcare wine capable of relieving eyestrain |
CN108260778A (en) * | 2016-12-30 | 2018-07-10 | 西藏天麦力健康品有限公司 | It is a kind of that there is protection eyesight, antifatigue health food and its processing method |
CN107997048A (en) * | 2017-11-29 | 2018-05-08 | 中国科学院兰州化学物理研究所 | A kind of composition for having effects that to improve eyesight |
CN107997048B (en) * | 2017-11-29 | 2021-03-30 | 中国科学院兰州化学物理研究所 | Composition with eyesight improving effect |
CN108095112A (en) * | 2017-12-18 | 2018-06-01 | 苏州诺衡生命科技有限公司 | One kind contributes to health food for relieving visual fatigues of health food and preparation method |
CN108079127A (en) * | 2017-12-31 | 2018-05-29 | 珠海大爱科技有限公司 | A kind of eye strain of releiving, dry and astringent, acid is swollen, promotes the moxa of uncorrected visual acuity |
CN108542970A (en) * | 2018-03-08 | 2018-09-18 | 安徽九华华源药业有限公司 | Alleviate the health products and preparation method thereof of asthenopia |
CN110384235A (en) * | 2018-04-20 | 2019-10-29 | 浙江新维士生物科技有限公司 | Improve food compositions, the oral preparation and preparation method thereof of visual fatigue |
CN109010375A (en) * | 2018-09-11 | 2018-12-18 | 厦门阿欧客健康科技有限公司 | A kind of collyrium |
CN109770364A (en) * | 2019-03-07 | 2019-05-21 | 通化禾韵现代农业股份有限公司 | With composition, the preparation method and application for alleviating visual fatigue function |
CN111248448A (en) * | 2020-02-10 | 2020-06-09 | 云南中科本草科技有限公司 | Composition for relieving eye fatigue, preparation method thereof and medicine or health food for relieving eye fatigue |
CN112586646A (en) * | 2020-02-28 | 2021-04-02 | 河北康平健康产业有限责任公司 | Solid beverage with eyesight protecting and asthenopia relieving functions and preparation method thereof |
CN113332362A (en) * | 2020-03-02 | 2021-09-03 | 张腾龙 | Application of pharmaceutical composition in preparing medicine for treating pseudomyopia |
CN112336761A (en) * | 2020-12-04 | 2021-02-09 | 广州陈锦济生物科技有限公司 | Anti-radiation eye moistening liquid and preparation method thereof |
CN113273690A (en) * | 2021-06-08 | 2021-08-20 | 烟台阿波罗生物药业科技有限公司 | New resource food for improving asthenopia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105878573A (en) | Composition for relieving visual fatigue | |
CN103417733B (en) | A kind of pharmaceutical composition of alleviating asthenopia | |
CN104397311A (en) | Blueberry composite tablet candy capable of relieving visual fatigue and preparation method thereof | |
CN107997048B (en) | Composition with eyesight improving effect | |
CN101856118A (en) | Health-care food for relieving asthenopia and preparation method thereof | |
CN103977157A (en) | Lycium ruthenicum eyesight-improving eye-protecting tea | |
CN104225265B (en) | A kind of Traditional Chinese medicine composition for relieving asthenopia | |
CN110354204B (en) | Composition with eyesight improving effect and preparation and application methods thereof | |
CN104256817A (en) | Functional drink with function of relieving visual fatigue and preparation method thereof | |
CN102626224A (en) | Eyesight improving agent composited by wild berries and Chinese medicines and preparation method thereof | |
CN112603971B (en) | Cordyceps militaris and pericarpium citri reticulatae traditional Chinese medicine composition, preparation method and application thereof | |
CN103766905B (en) | A kind of Herba Dendrobii Flos Chrysanthemi health care granule | |
CN109430856A (en) | A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue | |
CN104256617A (en) | Food, health care product or medicine composition with eyesight improving function | |
CN102178309B (en) | Formula for alfalfa semen cassiae health-care drink and preparation method | |
CN111528421A (en) | Eye-protecting product containing plant exosomes and preparation method thereof | |
CN106491947A (en) | A kind of composition for relieving asthenopia and its preparation | |
CN100486456C (en) | Health-care food used for reliefing eyestrain, and its preparing method | |
CN109010790A (en) | A kind of composition and its application for improving eye strain | |
CN105983004A (en) | Composition capable of alleviating asthenopia and preparation method | |
CN102894435A (en) | Mulberry-medlar leaf beverage with function of asthenopia relieving, and preparation method thereof | |
CN107156839A (en) | A kind of eyeshield health food and preparation method thereof | |
CN104337927A (en) | Calyx seu fructus physalis extractive, medicine composition and/or functional food | |
CN106262850A (en) | A kind of miscellaneous grain crops health instant powder and production technology | |
CN100387154C (en) | Health-care food for relieving-vision fatigue and its prepn. method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |
|
RJ01 | Rejection of invention patent application after publication |